6
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
article
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Possible Solutions Webinar Summary
Antimicrobial resistance (AMR) poses a threat to everyone. However, some patients with chronic illne
sses are significantly more likely to become infected with antibiotic-resistant bacteria than those without chronic disease.
+ Read More
article
National Institutes of Health (NIH) Director Nomination
Esther Krofah
Executive Vice President, Health
Executive Director, FasterCures and Center for Public
Health
Milken Institute
+ Read More
article
Statement at Multi-Stakeholder meeting in support of the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response
FasterCures would like to express our strong support for current initiatives to advance pandemic pre
vention, preparedness, and response. We appreciate the opportunity to provide our perspective in these critical discussions.
+ Read More
article
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006
Submitted electronically
Joni Rutter, Ph.D.
National Center for Advancing Translational Sciences
Na
tional Institutes of Health
6701 Democracy Blvd
Bethesda, MD 20892-4874
Dear Director Rutter,
+ Read More